These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 17496781)
1. Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides. Wolf M; Bauder-Wüst U; Eskerski H; Bauer C; Eisenhut M Melanoma Res; 2007 Apr; 17(2):61-73. PubMed ID: 17496781 [TBL] [Abstract][Full Text] [Related]
2. Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model. Wolf M; Eskerski H; Bauder-Wüst U; Haberkorn U; Eisenhut M Melanoma Res; 2006 Dec; 16(6):487-96. PubMed ID: 17119449 [TBL] [Abstract][Full Text] [Related]
3. Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation. Mansard S; Papon J; Moreau MF; Miot-Noirault E; Labarre P; Bayle M; Veyre A; Madelmont JC; Moins N Nucl Med Biol; 2005 Jul; 32(5):451-8. PubMed ID: 15982575 [TBL] [Abstract][Full Text] [Related]
4. Alkylating benzamides with melanoma cytotoxicity: role of melanin, tyrosinase, intracellular pH and DNA interaction. Wolf M; Bauder-Wüst U; Haberkorn U; Mier W; Eisenhut M Melanoma Res; 2005 Oct; 15(5):383-91. PubMed ID: 16179865 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives. Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507 [TBL] [Abstract][Full Text] [Related]
6. A high content screening assay for identifying lysosomotropic compounds. Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99. Lemieux B; Percival MD; Falgueyret JP Anal Biochem; 2004 Apr; 327(2):247-51. PubMed ID: 15051542 [TBL] [Abstract][Full Text] [Related]
8. Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy. Chehade F; De Labriolle-Vaylet C; Michelot J; Moins N; Moreau MF; Hindié E; Papon J; Escaig F; Galle P; Veyre A Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):529-34. PubMed ID: 11441960 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine. Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257 [TBL] [Abstract][Full Text] [Related]
10. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent. Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663 [TBL] [Abstract][Full Text] [Related]
11. Alkylating benzamides with melanoma cytotoxicity. Wolf M; Bauder-Wüst U; Mohammed A; Schönsiegel F; Mier W; Haberkorn U; Eisenhut M Melanoma Res; 2004 Oct; 14(5):353-60. PubMed ID: 15457090 [TBL] [Abstract][Full Text] [Related]
12. Increase of melanogenesis by retinoic acid: an ultrastructural and morphometric study. Fernandes SS; Arcuri R; Morgado-Díaz JA; Benchimol M Tissue Cell; 2004 Apr; 36(2):95-105. PubMed ID: 15041411 [TBL] [Abstract][Full Text] [Related]
13. Analysis of individual acidic organelles by capillary electrophoresis with laser-induced fluorescence detection facilitated by the endocytosis of fluorescently labeled microspheres. Fuller KM; Arriaga EA Anal Chem; 2003 May; 75(9):2123-30. PubMed ID: 12720351 [TBL] [Abstract][Full Text] [Related]
14. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation. Liu JW; Sun P; Yan Q; Paller AS; Gerami P; Ho N; Vashi N; Le Poole IC; Wang XQ Cancer Res; 2009 Nov; 69(22):8662-9. PubMed ID: 19903858 [TBL] [Abstract][Full Text] [Related]